REGN
Regeneron Pharmaceuticals Inc
$779.08
0.00%
0.00
Notify me if price changes either direction
Buy REGN stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
82.7B
Enterprise value
75.7B
Trailing PE
18.843773
Forward PE
14.891051
PEG Ratio
-5.0230432403125
Enterprise to EBITDA
17.82
Enterprise to revenue
5.275
Price to book MRQ
2.5675697
Price to sales TTM
5.76554
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2025-12-31
Revenue (TTM)
14.3B
EBITDA
5.0B
Diluted EPS TTM
41.51
Total Cash (MRQ)
8.6B
Current ratio (MRQ)
4.126
Operating Cash Flow (TTM)
5.0B
REGN trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
February 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
